Dr. Jack Cush reviews the highlights from the past week on RheumNow.com.
Tweet Content
Hydroxychloroquine Dose and Risk for Incident Retinopathy
A cohort study in Annals of Internal Medicine shows that higher hydroxychloroquine doses was associated with progressively greater risk for incident retinopathy.
https://t.co/DZ2UxDKgUD https://t.co/tFtNZc1Eza
Links
Poorer health outcomes for at-risk patients with fractures People at high risk of fracture are less likely to receive
Tweet Content
Poorer health outcomes for at-risk patients with fractures
People at high risk of fracture are less likely to receive treatment for the underlying osteoporosis and also have poorer health outcomes.
https://t.co/XmFcnBf6US https://t.co/mgAkb0NLBv
Links
Rx failures w/ nonmedical switching of biosimilars may be Nocebo effect. 140 #RA pts, 51 non-switchers & 89 switcher
Tweet Content
Rx failures w/ nonmedical switching of biosimilars may be Nocebo effect. 140 #RA pts, 51 non-switchers & 89 switchers. Non-switchers more likely to improve than switchers (68 vs 26%, p < 0.001) and less likely to worsen (1% vs 9%, p < 0.01). https://t.co/w8lnv1V5Pi https://t.co/iT2RkkSosl
Links
Naltrexone is indicated in opioid or EtOH dependence - not pain; yet it has wide off-label uses. Shown to be equal to El
Tweet Content
Naltrexone is indicated in opioid or EtOH dependence - not pain; yet it has wide off-label uses. Shown to be equal to Elavil in Rx of painful DM neuropathy; Little data from PBO RCTs in FM. Unclear how naltrexone modulates pain https://t.co/YZvfbHy9KJ https://t.co/6k9LfQSp1A
Links
What RheumNow Live attendees say about our meeting: "Great format w/shorter lectures, clinical content, good interface
Tweet Content
What RheumNow Live attendees say about our meeting:
"Great format w/shorter lectures, clinical content, good interface for audience participation to ask questions, and on-demand availability of videos post-meeting."
Join us!
https://t.co/AO0bqP5p54
@Janetbirdope @JoelKreme… https://t.co/d9ZhIbddgh
Links
New Guideline: Vaccinations OK for Rheum Patients Nearly all available vaccines can be given to people w/ rheumatologi
Tweet Content
New Guideline: Vaccinations OK for Rheum Patients
Nearly all available vaccines can be given to people w/ rheumatologic diseases, according to a new guideline from the ACR, though the timing for their administration and dosing may need adjustment.
https://t.co/kHWyrmjkuw https://t.co/LrcFrZR2TO
Links
PsART-ID study of 1216 #PsA pts showed PsA mortality to be similar to general population, but during pandemic PsA mortal
Tweet Content
PsART-ID study of 1216 #PsA pts showed PsA mortality to be similar to general population, but during pandemic PsA mortality doubled (5.1 vs 10.86 pandemic) with a higher increase in females (2.9 vs 8.72) than males (9.07 vs 14.73) https://t.co/AzhjOlW8vh https://t.co/YF7OlEh0sK
Links